Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0035412 (
rhabdomyosarcoma
)
6,156
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
RASSF4
, a member of the classical RASSF family of scaffold proteins, is associated with alveolar
rhabdomyosarcoma
, an aggressive pediatric cancer of muscle histogenesis. However, the role of
RASSF4
in normal myogenesis is unknown. We demonstrate here that
RASSF4
is necessary for early in vitro myogenesis. Using primary human myoblasts, we show that
RASSF4
expression is dramatically increased during in vitro myogenic differentiation, and conversely that
RASSF4
-deficient myoblasts cannot differentiate, potentially because of a lack of upregulation of myogenin. In microscopy studies, we show that
RASSF4
protein co-localizes with proteins of the myogenic microtubule-organizing center (MTOC) both before and after myogenic differentiation.
RASSF4
-deficient cells subject to differentiation conditions demonstrate a lack of shape change, suggesting that
RASSF4
plays a role in promoting microtubule reorganization and myoblast elongation. In biochemical studies of myotubes,
RASSF4
associates with MST1, suggesting that
RASSF4
signals to MST1 in the myogenic differentiation process. Expression of MST1 in myoblasts partially reversed the effect of
RASSF4
knockdown on differentiation, suggesting that
RASSF4
and MST1 coordinately support myogenic differentiation. These data show that
RASSF4
is critical for the early steps of myogenic differentiation.
...
PMID:RASSF4 is required for skeletal muscle differentiation. 3150 57